Pretreatment with epidermal growth factor enhances naked plasmid DNA transfer onto gastric serosal surface in mice

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

We have developed a simple administration method, which is gastric serosal surface instillation of naked plasmid DNA (pDNA) in experimental animals. The purpose of this study was to improve gastric gene transfer efficiency by pre-treatment with a macropinocytosis enhancer, such as fetuin or epidermal growth factor (EGF), in mice. A series of concentrations of fetuin were instilled onto gastric serosal surface prior to instillation of naked pDNA in mice; however, fetuin did not improve transgene expression in the stomach 6 h after administration of pDNA. EGF also did not affect transgene expression in the stomach when pDNA was instilled immediately after EGF instillation. On the other hand, when pDNA was instilled onto gastric serosal surface 24 h after EGF treatment, transgene expression in the stomach was significantly improved by 2.6-fold. In addition, transgene-positive cells were increased 5.3-fold by EGF pre-treatment. High transgene expression in the stomach lasted for 48 h in the EGF pre-treatment group in comparison with that in the no pre-treatment group. These findings are valuable to develop an effective method of in vivo gene transfer to the stomach. © 2012 The Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Miyamoto, H., Baba, S., Nakajima, S., Mine, T., Yoshikawa, N., Fumoto, S., & Nishida, K. (2012). Pretreatment with epidermal growth factor enhances naked plasmid DNA transfer onto gastric serosal surface in mice. Biological and Pharmaceutical Bulletin, 35(6), 903–908. https://doi.org/10.1248/bpb.35.903

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free